Target Price Playground

GSK
$47.76
IV 35.0% Target $82.77 (+73.3%)

LEAP Setup

1-Click Institutional Target Anchors:
6m
9m
12m
18m
24m

Quick Stats

Current Price
$47.76
Target Move
+73.3%
Horizon
12 months
ATM Breakeven
$56.56
Profit Path — If GSK Trends to $83
Assumes linear price movement from $48 to $83 over 12 months
Deep ITM (Stock Repl.) ($40) ATM ($50) 10% OTM ($55) 20% OTM ($55) Break-even
Scenario Matrix — ATM $50 Call
Price % Today Feb 18 May 19 Aug 17 Nov 15 (exp)
$38 -20% -$425 -$497 -$569 -$633 -$656
$41 -15% -$342 -$425 -$515 -$606 -$656
$43 -10% -$243 -$338 -$443 -$561 -$656
$45 -5% -$129 -$232 -$350 -$492 -$656
$47 -2% -$53 -$162 -$286 -$439 -$656
$48 0% -$0 -$111 -$238 -$397 -$656
$49 +2% +$56 -$57 -$188 -$351 -$656
$50 +5% +$142 +$27 -$107 -$275 -$641
$53 +10% +$297 +$179 +$43 -$127 -$402
$55 +15% +$462 +$344 +$208 +$43 -$164
$57 +20% +$638 +$520 +$388 +$232 +$75
$83 TARGET +73.3% +$2,891 +$2,813 +$2,740 +$2,677 +$2,621
Insights
Reasonable IV
IV at 35% is in the normal range (25-45%). Premiums are fairly priced.
6.5x Leverage
The 10% OTM $55 call gives 6.5x leverage vs buying stock. Every 1% move in GSK translates to ~6.5% on the option.
All Strikes Profitable
If GSK hits $83, all four strikes are profitable. Best ROI is 478% on the 10% OTM strike.
Breakeven: $57 (+18%)
GSK needs to reach $57 (+18% from here) by expiry just to break even on the ATM call. Your target of $83 is above this level.
Theta: $1/day ($35/mo)
This contract expires in 360 days (~12 months). Initial time decay costs ~$35/month (~$104 or 15.9% of entry cost over the next 90 days) and accelerates non-linearly inside the final 60–90 DTE.

LEAP Options

Deep ITM (Stock Repl.) EST
$40 Call
Exp: Nov 15, 2027 (360d)
Entry / Contract
$1,183
Profit at Target
$3,066
ROI
259.1%
Leverage vs Stock
3.5x
Breakeven Price
$51.83
Extrinsic Value
$4.07 (34.4%)
PMCC Monthly Income (~30d $53 Call): ~$49/mo (49.8% ann. yield on LEAP)
Δ 0.791
Θ $-0.98/d
Vega 0.14
ATM EST
$50 Call
Exp: Nov 15, 2027 (360d)
Entry / Contract
$656
Profit at Target
$2,594
ROI
395.4%
Leverage vs Stock
5.4x
Breakeven Price
$56.56
Extrinsic Value
$6.56 (100.0%)
Out-of-the-money leverage play (PMCC requires Deep ITM ≥0.70Δ)
Δ 0.567
Θ $-1.16/d
Vega 0.19
10% OTM BEST PICK EST
$55 Call
Exp: Nov 15, 2027 (360d)
Entry / Contract
$476
Profit at Target
$2,274
ROI
477.5%
Leverage vs Stock
6.5x
Breakeven Price
$59.76
Extrinsic Value
$4.76 (100.0%)
Out-of-the-money leverage play (PMCC requires Deep ITM ≥0.70Δ)
Δ 0.458
Θ $-1.13/d
Vega 0.19
20% OTM EST
$55 Call
Exp: Nov 15, 2027 (360d)
Entry / Contract
$476
Profit at Target
$2,274
ROI
477.5%
Leverage vs Stock
6.5x
Breakeven Price
$59.76
Extrinsic Value
$4.76 (100.0%)
Out-of-the-money leverage play (PMCC requires Deep ITM ≥0.70Δ)
Δ 0.458
Θ $-1.13/d
Vega 0.19